The store will not work correctly when cookies are disabled.
2,3-Dichloro-N-(3-ethoxy-1H-pyrazolo[3,4-d]pyrimidin-4-yl)benzenesulfonamide
ID: ALA4091069
PubChem CID: 137644970
Max Phase: Preclinical
Molecular Formula: C13H11Cl2N5O3S
Molecular Weight: 388.24
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCOc1n[nH]c2ncnc(NS(=O)(=O)c3cccc(Cl)c3Cl)c12
Standard InChI: InChI=1S/C13H11Cl2N5O3S/c1-2-23-13-9-11(18-19-13)16-6-17-12(9)20-24(21,22)8-5-3-4-7(14)10(8)15/h3-6H,2H2,1H3,(H2,16,17,18,19,20)
Standard InChI Key: VDRMWPDDONONGM-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
30.8381 -11.2754 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.2524 -10.5611 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
30.4267 -10.5595 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.9699 -10.9698 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.2538 -9.7344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9687 -9.3263 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9676 -8.5013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2514 -8.0889 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5347 -8.5074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5392 -9.3310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4537 -11.9540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4499 -13.2902 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.9376 -12.6240 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.6655 -13.0322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6719 -12.2103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9643 -11.7957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2500 -12.2018 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.2477 -13.0269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9558 -13.4377 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.6831 -9.7403 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
32.6822 -8.0875 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
33.7091 -11.1688 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.5168 -10.9972 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.7720 -10.2120 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 2 1 0
2 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 15 1 0
14 12 1 0
12 13 1 0
13 11 2 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
16 4 1 0
6 20 1 0
7 21 1 0
11 22 1 0
22 23 1 0
23 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 388.24 | Molecular Weight (Monoisotopic): 386.9960 | AlogP: 2.86 | #Rotatable Bonds: 5 |
Polar Surface Area: 109.86 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 5.60 | CX Basic pKa: 0.58 | CX LogP: 2.82 | CX LogD: 1.90 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.70 | Np Likeness Score: -1.84 |
References
1. Miah AH, Champigny AC, Graves RH, Hodgson ST, Percy JM, Procopiou PA.. (2017) Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists., 25 (20): [PMID:28801066] [10.1016/j.bmc.2017.07.052] |